Suppliers / Shanghai Sinuotides Biopharmaceutical

Shanghai Sinuotides Biopharmaceutical

China Updated 9 July 2026

Shanghai Sinuotides Biopharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Nusinersen US FDA 2

Also appears on these molecule pages

Nusinersen API

Questions about Shanghai Sinuotides Biopharmaceutical

Does Shanghai Sinuotides Biopharmaceutical hold a US DMF or a CEP?
Shanghai Sinuotides Biopharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shanghai Sinuotides Biopharmaceutical make?
1 molecule is on record against Shanghai Sinuotides Biopharmaceutical, including Nusinersen. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shanghai Sinuotides Biopharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Natco Pharma shares 1 molecule Synthon shares 1 molecule Chongqing Carelife Pharmaceutical shares 1 molecule Yangzhou Aurisco Pharmaceutical shares 1 molecule Sichuan Gowell Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability